Skip to main content
Share On
Donation
Donation period
Choose an option
One-Time
Monthly
Secondary navigation
About Us
News
Events
Blogs
Advocacy
Fundraise
Search
Donate Now
Main navigation
What Is Multiple Myeloma?
Newly Diagnosed
Do You Have Myeloma?
Multiple Myeloma Diagnostic Criteria
MGUS, Smoldering Myeloma, and Myeloma
Types of Myeloma
Urgent Problems at Diagnosis
Is Multiple Myeloma Curable?
FAQ
Tests and Staging
What Tests Do You Need?
Tests to assess blood cells
Tests to assess kidney function
Tests to assess proteins and other substances in the blood
Tests to assess monoclonal protein
Bone marrow tests
Imaging studies
MRD and Mass Spectrometry Testing
Staging and Risk Stratification
International Staging System (ISS) and Revised ISS (R-ISS)
Treatment
What Are First-Line Treatments?
Role of Transplant
Role of Consolidation
Role of Maintenance/Continuous Therapy
What Is Relapse?
Multiple Myeloma Medications
ABECMA® (idecabtagene vicleucel)
AREDIA® (pamidronate disodium)
BLENREP (belantamab mafodotin-blmf)
CARVYKTI (ciltacabtagene autoleucel)
CYTOXAN® (cyclophosphamide)
DARZALEX® (daratumumab)
DARZALEX FASPRO (daratumumab and hyaluronidase-fihj)
Dexamethasone
EMPLICITI® (elotuzumab)
KYPROLIS® (carfilzomib)
Melphalan (ALKERAN®)
NINLARO® (ixazomib)
POMALYST® (pomalidomide)
REVLIMID® (lenalidomide)
Sarclisa (isatuximab-irfc)
TALVEY (talquetamab)
TECVAYLI (teclistamab-cqyv)
THALOMID® (thalidomide)
VELCADE® (bortezomib)
Xgeva (denosumab)
Xpovio (selinexor)
Zometa (zoledronic acid)
Side Effects Management
Anemia
Bone Disease
Distress, Fatigue, and Sexuality
Gastrointestinal Problems
Heart and Lung Complications
Kidney Failure
Myelosuppression
Pain Management
Palliative Care
Peripheral Neuropathy
Steroid Side Effects
Emerging Therapies
Immune Therapy
Clinical Trials
A Clinical Trials Glossary
Clinical Trials Fact Sheets
Long-Term Care Planning
Mobility and safety
Routine health maintenance
Publications and Videos
IMF Publications
Patient Handbook
Understanding Series
Myeloma Minute
Myeloma Today
Tip Cards
Foreign Language Resources
IMF Videos
Black Swan Research Initiative
IMWG Conference Series
Living Well With Myeloma
Patient and Family Seminars
Community Workshop
Nurse Leadership Board Series
Patient Stories - Podcasts
Myeloma Information
Healthcare Professional Resources
IMWG Publications
Nurse Leadership Board Summaries
ASH Abstract Summaries
ASCO Abstract Summaries
CME & Education
Doctors' Edition: Proteasome Inhibitors
Getting Clear Answers to Complex Treatment Challenges in Multiple Myeloma
Resources and Support
IMF Support Network
Find a Support Group
Contact the InfoLine
Care Partner Resources
Find a Clinical Trial
Myeloma Knowledge Platform
Patient and Family Seminars
Myeloma Community Workshops
Weekly Newsletter
Mind and Body Wellness
The Patient Perspective at ASH
Diversity, Equity, and Inclusion
Disparities in Healthcare
Disparities in African Americans
Disparities in Hispanic Americans
Disparities in Other Races and Ethnicities in the U.S.
Disparities in Access to Clinical Trials and New Therapies
M-Power Initiative
External Resources
Drug Reimbursement and Co-Pay Assistance Resources
Financial Resources
Government Resources
Counseling and Support Resources
Housing and Travel Resources
International Support
Legal Resources
Pain Management Resources
Transplant Resources
Other Cancer Resources
Our Research
IMF Medical Research
Black Swan Research Initiative
Black Swan Research Projects
Black Swan Publications
Contact the Black Swan Research Initiative
International Myeloma Working Group
International Myeloma Working Group (IMWG) Publications
International Myeloma Working Group (IMWG) Conference Series
Asian Myeloma Network
Multiple Myeloma in Asia
Myeloma Clinical Trials in Asia
Latin American Myeloma Network
Road to the Cure
Nurse Leadership Board
Nurse Leadership Board Members
Nurse Leadership Board Publications
Nursing Resources
Myeloma University
IMF Research Awards
Brian D. Novis Research Grants
Kyle Lifetime Achievement Award
Brian G.M. Durie Outstanding Achievement Award
Ways to Give
Ways to Give
Major Giving
Monthly and Annual Giving
Matching Gifts
Planned Giving
Corporate Giving
Stock/IRA Donation
Create a Tribute
Other Ways to Give
Community Fundraising
Iceland Cycling Expedition
Run/Walk Events
Vehicle Donation
End of Year Giving
Be An Advocate
U.S. Advocacy
Global Advocacy (GMAN)
Global Myeloma Action Network (GMAN) Annual Summit
Multiple Myeloma: International Bill of Rights
EU Drug Approval and Reimbursement Policy
Veterans Against Myeloma
Myeloma Action Month
Blood Cancer Awareness Month
About Us
News
Events
Blogs
Advocacy
Fundraise
Donate Now
What is multiple myeloma?
Start Here
Learn more about multiple myeloma
Visit Our Library
No matter the situation, we are here for you
How can we help
The fight against myeloma starts here
The Road to the Cure
Your donation brings us closer to a cure
How Your Gift Helps
Donate
Myeloma Minute
IMF History
IMF History
January 13
A Bold Vision for the Future of Myeloma Care and Support
IMF History
June 19
IMF GMAN: Global Myeloma Action Network Leads Advocacy Efforts Worldwide
IMF History
July 24
What Is the Global Myeloma Action Network?
IMF History
January 23
The International Myeloma Foundation's (IMF) Impact in 2022 and the Future of the IMF
IMF History
February 15
CEO of the International Myeloma Foundation Yelak Biru Shares His Vision for the Future.
IMF History
November 6
30 years of scientific achievement with multiple myeloma patient care at the heart of it all.
IMF History
June 12
IMF Co-founders Receive a Joint Honorary Doctorate in Recognition of Scientific Excellence
IMF History
May 10
Brian D. Novis Grant Awardees 2017
IMF History
May 10
One Myeloma Nation
Subscribe to IMF History
Give Where Most Needed
$25
$50
$100
$150
$250
Other
Learn More
